NCT06973122 Paragastric Neural Blockade and Laparoscopic Assisted Transversus Abdominis Plane Block on Visceral Pain After Surgery
| NCT ID | NCT06973122 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alexandria University |
| Condition | Visceral Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-04 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-04-04 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
after laparoscopic bariatric surgery, visceral pain (VP) remains a significant issue. VP causes autonomic symptoms, such as nausea and vomiting, and does not respond to conventional pain management methods that target incisional pain. The present study was performed to test the effect of use of combined paragastric autonomic neural blockade and laparoscopic assisted transversus abdominis plane block on visceral pain during laparoscopic bariatric surgery and in the early postoperative period.
Eligibility Criteria
Inclusion Criteria: * Age: 20-50 years, both sexes. * ASA physical status class I to III. * BMI 35- 50 kg/m² Exclusion Criteria: * Severe cardiac disorder * chronic renal failure * liver cirrhosis * allergy to bupivacaine * patients with history of chronic opioid consumption * HBA1C \> 7%
Contact & Investigator
sarah m elgamal, MD
PRINCIPAL INVESTIGATOR
Alexandria University
Frequently Asked Questions
Who can join the NCT06973122 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Visceral Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06973122 currently recruiting?
Yes, NCT06973122 is actively recruiting participants. Contact the research team at sarahelgamal1990@yahoo.com for enrollment information.
Where is the NCT06973122 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT06973122 clinical trial?
NCT06973122 is sponsored by Alexandria University. The principal investigator is sarah m elgamal, MD at Alexandria University. The trial plans to enroll 120 participants.